Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: CLOVERLEAF BIO, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-15 to 2026-09-14
Current total value of award: $355000
Description: SBIR FY25 CONCEPT AWARD: DEVELOPMENT OF ENGINEERED TRNA THERAPEUTICS FOR CLEAR CELL RENAL CELL CARCINOMA